Design, synthesis and preliminary SAR studies of novel N-arylmethyl substituted piperidine-linked aniline derivatives as potent HIV-1 NNRTIs

被引：23

作者：

Zhang, Lingzi ^{[1
]}

Zhan, Peng ^{[1
]}

Chen, Xuwang ^{[1
]}

Li, Zhenyu ^{[1
]}

Xie, Zhoumeng ^{[1
]}

Zhao, Tong ^{[1
]}

Liu, Huiqing ^{[3
]}

De Clercq, Erik ^{[2
]}

Pannecouque, Christophe ^{[2
]}

Balzarini, Jan ^{[2
]}

Liu, Xinyong ^{[1
]}

机构：

[1] Shandong Univ, Sch Pharmaceut Sci, Dept Med Chem, Key Lab Chem Biol,Minist Educ, Jinan 250012, Shandong, Peoples R China

[2] Katholieke Univ Leuven, Rega Inst Med Res, B-3000 Louvain, Belgium

[3] Shandong Univ, Inst Pharmacol, Sch Med, Jinan 250012, Shandong, Peoples R China

来源：

BIOORGANIC & MEDICINAL CHEMISTRY | 2014年 / 22卷 / 01期

基金：

中国国家自然科学基金; 高等学校博士学科点专项科研基金;

关键词：

HIV-1; AIDS; NNRTIs; Synthesis; Anti-HIV-1; activity; REVERSE-TRANSCRIPTASE INHIBITORS; COLORIMETRIC ASSAY; ANTAGONISTS; DISCOVERY; AIDS; DNA;

D O I：

10.1016/j.bmc.2013.10.033

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

A series of novel N-arylmethyl substituted piperidine-linked aniline derivatives were designed, synthesized and evaluated for their anti-HIV activity in MT-4 cells. All the new compounds showed moderate to potent activities against wild-type (wt) HIV-1 with an EC50 range from 0.022 to 2.1 mu M. Among them, compound 5a6 (EC50 = 0.022 +/- 0.0091 mu M, SI > 10,770) was confirmed to be the most potent and selective inhibitor, which proved more potent than DDI and DLV in a cell-based assay against wt HIV-1, and more efficient than NVP in an RT (reverse transcriptase) assay. Besides, it is worth noting that compound 7a1 retained moderate inhibitory activity (EC50 = 4.8 +/- 0.95 mu M) against the HIV-1 double RT mutant strain (K103N/Y181C). The preliminary structure-activity relationship was discussed and rationalized by molecular simulation. (C) 2013 Elsevier Ltd. All rights reserved.

引用

页码：633 / 642

页数：10

共 40 条

[31] Novel N-Substituted oseltamivir derivatives as potent influenza neuraminidase inhibitors: Design, synthesis, biological evaluation, ADME prediction and molecular docking studies [J].

Ye, Jiqing ;

Yang, Xiao ;

Xu, Min ;

Chan, Paul Kay-sheung ;

Ma, Cong .

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 182

[32] Synthesis and biological evaluation of novel amprenavir-based P1-substituted bi-aryl derivatives as ultra-potent HIV-1 protease inhibitors [J].

Yan, Jianwei ;

Huang, Ning ;

Li, Shukun ;

Yang, Liu-Meng ;

Xing, Weiqiang ;

Zheng, Yong-Tang ;

Hu, Youhong .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (05) :1976-1979

[33] Design, synthesis and biological evaluation of N2,N4-disubstituted-1,1,3-trioxo-2H,4H-pyrrolo[1,2-b][1,2,4,6]thiatriazine derivatives as HIV-1 NNRTIs [J].

Chen, Wenmin ;

Zhan, Peng ;

De Clercq, Erik ;

Pannecouque, Christophe ;

Balzarini, Jan ;

Jiang, Xin ;

Liu, Xinyong .

BIOORGANIC & MEDICINAL CHEMISTRY, 2013, 21 (22) :7091-7100

[34] Design, Synthesis and X-ray Structural Studies of Potent HIV-1 Protease Inhibitors Containing C-4 Substituted Tricyclic Hexahydro-furofuran Derivatives as P2 Ligands [J].

Ghosh, Arun K. ;

Kovela, Satish ;

Sharma, Ashish ;

Shahabi, Dana ;

Ghosh, Ajay K. ;

Hopkins, Denver R. ;

Yadav, Monika ;

Johnson, Megan E. ;

Agniswamy, Johnson ;

Wang, Yuan-Fang ;

Hattori, Shin-Ichiro ;

Higashi-Kuwata, Nobuyo ;

Aoki, Manabu ;

Amano, Masayuki ;

Weber, Irene T. ;

Mitsuya, Hiroaki .

CHEMMEDCHEM, 2022, 17 (09)

[35] Design, synthesis, evaluation and X-ray structural studies of potent HIV-1 protease inhibitors containing substituted oxaspirocyclic carbamates as the P2 ligands [J].

Ghosh, Arun K. ;

Shaktah, Ryan ;

Ghosh, Ajay K. ;

Johnson, Megan E. ;

Bhandari, Dipendra ;

Amano, Masayuki ;

Aoki, Manabu ;

Kovalevsky, Andrey ;

Mitsuya, Hiroaki .

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2025, 297

[36] Design, Synthesis, and Preclinical Evaluations of Novel 4-Substituted 1,5-Diarylanilines as Potent HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) Drug Candidates [J].

Sun, Lian-Qi ;

Zhu, Lei ;

Qian, Keduo ;

Qin, Bingjie ;

Huang, Li ;

Chen, Chin Ho ;

Lee, Kuo-Hsiung ;

Xie, Lan .

JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (16) :7219-7229

[37] Synthesis, HIV-1 RT inhibitory, antibacterial, antifungal and binding mode studies of some novel N-substituted 5-benzylidine-2,4-thiazolidinediones [J].

Bahare, Radhe Shyam ;

Ganguly, Swastika ;

Choowongkomon, Kiattawee ;

Seetaha, Supaporn .

DARU-JOURNAL OF PHARMACEUTICAL SCIENCES, 2015, 23

[38] Synthesis, HIV-1 RT inhibitory, antibacterial, antifungal and binding mode studies of some novel N-substituted 5-benzylidine-2,4-thiazolidinediones [J].

Radhe Shyam Bahare ;

Swastika Ganguly ;

Kiattawee Choowongkomon ;

Supaporn Seetaha .

DARU Journal of Pharmaceutical Sciences, 23

[39] Arylazolylthioacetanilide. Part 8: Design, synthesis and biological evaluation of Novel 2-(2-(2,4-Dichlorophenyl)-2H-1,2,4-triazol-3-ylthio)-N-arylacetamides As Potent HIV-1 inhibitors [J].

Zhan, Peng ;

Chen, Xuwang ;

Li, Xiao ;

Li, Dongyue ;

Tian, Ye ;

Chen, Wenwen ;

Pannecouque, Christophe ;

De Clercq, Erik ;

Liu, Xinyong .

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2011, 46 (10) :5039-5045

[40] Design, synthesis and biological evaluation of 3-substituted 2,5-dimethyl-N-(3-(1H-tetrazol-5-yl)phenyl)pyrroles as novel potential HIV-1 gp41 inhibitors [J].

He, Xiao-Yang ;

Zou, Peng ;

Qiu, Jiayin ;

Hou, Ling ;

Jiang, Shibo ;

Liu, Shuwen ;

Xie, Lan .

BIOORGANIC & MEDICINAL CHEMISTRY, 2011, 19 (22) :6726-6734

← 1 2 3 4 →